Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$5.05bnn/an/a
au flag iconMSBMesoblastAU$2.82bnn/an/a
au flag iconPYCPYC TherapeuticsAU$1.21bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.09bnn/an/a
au flag iconRACRacura OncologyAU$511.72mn/an/a
au flag iconCGSCogstateAU$418.59m28.270.76%
au flag iconTTXTetratherixAU$238.07mn/an/a
au flag iconDXBDimerixAU$228.15mn/an/a
au flag iconBXNBioxyneAU$146.88m17.1n/a
au flag iconNYRNyradaAU$142.31mn/an/a
au flag iconACWActinogen MedicalAU$140.22mn/an/a
au flag iconATHAlterity TherapeuticsAU$108.75mn/an/a
au flag iconIMMImmutepAU$103.16mn/an/a
au flag iconILAIsland PharmaceuticalsAU$100.89mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$96.42mn/an/a
au flag iconALAArovella TherapeuticsAU$92.49mn/an/a
au flag iconATXAmplia TherapeuticsAU$84.66mn/an/a
au flag iconCYPCynata TherapeuticsAU$83.11mn/an/a
au flag iconLTPLtr PharmaAU$70.84mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a